Clinical Trial

Heart Rate Control Before Cardiac Computed Tomography in Adults for the Evaluation of Coronary Artery Disease

Study acronym: HEART-BEAT
Enrolling by Invitation Phase 2/3
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to describe which type and dose of commonly used heart rate reducing drugs (metoprolol, atenolol, or ivabradine) has the swiftest heart rate reduction from baseline in patients aged 30 to 80 years with a heart rate \> 65 beats per minute undergoing cardiac computed tomography for the evaluation of coronary artery disease. The main question it aims to answer is • Which type of heart reducing drug and dose has the swiftest heart rate reduction before cardiac computed tomography?
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-12-03; most recent amendment 2025-12-16.
Status change: Not Yet Recruiting → Enrolling by Invitation 2025-12-11
Trial Details
NCT Number NCT07268170
Lead Sponsor Gødstrup Hospital
Conditions Coronary Arterial Disease (CAD), Ischemic Heart Disease (IHD)
Enrollment 350 participants
Start Date 2025-12-15
Primary Completion 2028-09-01 (estimated)
Study Completion 2028-09-30 (estimated)
Updated on ClinicalTrials.gov 2025-12-17